Campbell Soup Co. stock: High yield amid sales struggles—what's next?

Campbell Soup Co. stock offers a compelling 7% dividend yield as shares trade near 52-week lows, but recent earnings misses raise questions for your portfolio. North American investors can weigh steady payouts against growth hurdles in this consumer staple. ISIN: US1280301048

You're eyeing Campbell Soup Co. stock right now, and it's delivering a standout **7% dividend yield** amid a tough stretch for shares hovering near their 52-week lows. The company, listed on **NASDAQ** under ticker CPB (ISIN: US1280301048) in USD, just faced a fiscal Q2 earnings miss that sent the stock tumbling, but its reliable payouts and undervaluation signals keep income-focused investors circling back.

As of: 03.04.2026

By Elena Vargas, Senior Equity Analyst: Campbell Soup Co. navigates a shifting consumer landscape in packaged foods, where brand loyalty meets pricing pressures head-on.

Campbell's Core Business: Soups, Snacks, and Staples

Campbell Soup Co. has long been a household name for you in North America, built on iconic canned soups that have warmed kitchens for generations. Beyond soups, the company spans meals and beverages through brands like Prego, Swanson, and V8, while snacks under Pepperidge Farm and Goldfish target everyday indulgence.

You know these products from grocery runs—reliable, shelf-stable options that thrive when consumers prioritize value. The meals and beverages segment drives the bulk of revenue, with snacks adding growth potential in a category less tied to economic cycles. This mix positions Campbell's as a defensive play in the **consumer staples sector**.

For your portfolio, this means exposure to essential goods that hold up better during slowdowns. But with inflation squeezing budgets, Campbell's must balance price hikes with volume retention—a dynamic playing out in recent quarters. Trading on NASDAQ in USD, CPB gives you straightforward access to this legacy business.

Recent Performance: Earnings Miss and Guidance Cut

The fiscal Q2 results hit hard, with Campbell's missing estimates and trimming full-year guidance to a 1-2% organic sales decline. Shares plunged over 7% in one session post-release on March 11, 2026, reflecting investor frustration with fading momentum.

You saw year-to-date returns down around 19% and one-year total shareholder returns off 40%, though a short-term rebound hints at bargain hunting. At levels around $22, the stock sits well below its 52-week high of $40.44, with a low of $20.62 underscoring the pressure.

This isn't just noise—it's a signal of broader challenges like softening demand and competitive pricing wars. For you as a North American investor, these moves highlight why timing matters in staples: even defensive names can lag when growth stalls.

Dividend Strength: Your 7% Yield Anchor

Amid the turbulence, Campbell's dividend stands out as a bright spot for yield seekers like you. The company pays a quarterly dividend, recently set at $0.39 per share, delivering an annual payout of $1.56 and a yield around **7%**—among the highest in its peer group.

Ex-dividend dates roll quarterly, with the next around early April 2026, payable later that month. The payout ratio hovers near 85%, supported by steady cash flows from core brands, and the company has grown dividends modestly over time.

You get reliability here: Campbell's has maintained payouts through cycles, making CPB appealing for income strategies. In a market chasing yield without excessive risk, this feature alone justifies a closer look, especially at depressed prices.

Valuation Case: Undervalued or Value Trap?

Analyses peg Campbell's as undervalued, with fair value estimates ranging from $25 to significantly higher, implying 10-60% upside from recent $22 levels. A value score of 4/6 and trading at a discount to peers bolsters the bull case.

Revenue growth forecasts sit flat at -0.43% annually, but earnings could expand 12.3% per year through margins from cost savings—targeting $375 million in efficiencies. Debt coverage remains a watch item, but operational tweaks offer tailwinds.

For you, this setup poses the key question: Is the pullback pricing in permanent weakness, or does it create a buy window? Snowflake metrics rate valuation highly at 5/6, dividends perfect at 6/6, but future growth lags at 1/6—balancing opportunity with caution.

Analyst Perspectives: Cautious Optimism Prevails

Reputable analyses from platforms tracking bank research highlight Campbell's dividend reliability and undervaluation, though growth concerns temper enthusiasm. Simply Wall St's narrative fair value of $25.24 suggests 11-60% undervaluation depending on the model, driven by margin expansion and steady revenue.

You'll find consensus leaning toward hold territory, with Zacks referencing a short-term rating system that weighs timeliness. Earnings forecasts show beats in recent quarters, like Q1's $0.73 vs. $0.65 expected, but next quarter anticipates a dip to $0.56.

Banks and firms see the cost savings as a multi-year earnings booster, yet sales guidance cuts have split sentiment between opportunity and worry. For North American investors, this points to monitoring execution on efficiencies amid consumer shifts.

Why It Matters for You in North America

As a North American investor, Campbell's resonates because it's woven into your daily life—from school lunches with Goldfish to quick Swanson broth dinners. The U.S. market dominates its footprint, making CPB a pure play on domestic consumer trends.

You benefit from its scale in distribution and brand equity, which fend off smaller rivals. In a high-interest-rate world, the yield provides ballast, while proximity to lows offers entry points if sales stabilize. Watch grocery inflation and private-label competition—they directly hit your returns.

This stock fits income-diversified portfolios, especially if you're balancing tech volatility with staples stability. Relevance spikes now as economic uncertainty favors dividend payers over growth bets.

Risks and What to Watch Next

Key risks loom for you: persistent sales declines could erode margins if cost savings falter, and high debt relative to cash flow adds leverage risk in a rising-rate environment. One-off items have clouded past results, per analyses.

Competition from fresh foods and plant-based alternatives challenges canned dominance, while pricing power wanes if consumers trade down. Beta near zero signals low volatility, but recent drops prove even staples swing.

Watch the next earnings on September 4, 2025, for sales traction and savings progress. Upcoming dividend ex-date in April 2026 offers yield capture if you time entry right. For your moves, track consumer spending data—it's the pulse for CPB's rebound.

Should you buy now? If yield and undervaluation align with your risk tolerance, yes—especially near lows. Otherwise, wait for sales stabilization signals. This balance of income reliability and growth questions makes Campbell's worth your ongoing attention.

Disclaimer: Not investment advice. Stocks are volatile financial instruments.